Hepatectomy for Stage B and Stage C Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer Classification: Results of a Prospective Analysis | Gastroenterology | JAMA Surgery | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
Fattovich  GGiustina  GDegos  F  et al.  Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.  Gastroenterology 1997;112 (2) 463- 472PubMedGoogle ScholarCrossref
Bruix  JLlovet  JM Prognostic prediction and treatment strategy in hepatocellular carcinoma.  Hepatology 2002;35 (3) 519- 524PubMedGoogle ScholarCrossref
Llovet  JMFuster  JBruix  JBarcelona-Clinic Liver Cancer Group, The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.  Liver Transpl 2004;10 (2) ((suppl 1)) S115- S120PubMedGoogle ScholarCrossref
Marrero  JA Staging systems for hepatocellular carcinoma: should we all use the BCLC system?  J Hepatol 2006;44 (4) 630- 632PubMedGoogle ScholarCrossref
Imamura  HSeyama  YKokudo  N  et al.  One thousand fifty-six hepatectomies without mortality in 8 years.  Arch Surg 2003;138 (11) 1198- 1206PubMedGoogle ScholarCrossref
Torzilli  GMakuuchi  MInoue  K  et al.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? a prospective analysis of our approach.  Arch Surg 1999;134 (9) 984- 992PubMedGoogle ScholarCrossref
Fan  STLo  CMLiu  CL  et al.  Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths.  Ann Surg 1999;229 (3) 322- 330PubMedGoogle ScholarCrossref
Ng  KKVauthey  JNPawlik  TM  et al. International Cooperative Study Group on Hepatocellular Carcinoma, Is hepatic resection for large or multinodular hepatocellular carcinoma justified? results from a multi-institutional database.  Ann Surg Oncol 2005;12 (5) 364- 373PubMedGoogle ScholarCrossref
Minagawa  MMakuuchi  MTakayama  TOhtomo  K Selection criteria for hepatectomy in patients with hepatocellular carcinoma and portal vein tumor thrombus.  Ann Surg 2001;233 (3) 379- 384PubMedGoogle ScholarCrossref
Pawlik  TMPoon  RTAbdalla  EK  et al.  Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study.  Surgery 2005;137 (4) 403- 410PubMedGoogle ScholarCrossref
Ikai  IYamamoto  YYamamoto  N  et al.  Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins.  Surg Oncol Clin N Am 2003;12 (1) 65- 75PubMedGoogle ScholarCrossref
Couinaud  C Le Foie: Etude Anatomiques et Chirurgicales.  Paris, France Masson Publishers1957;
Mazzaferro  VRegalia  EDoci  R  et al.  Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.  N Engl J Med 1996;334 (11) 693- 699PubMedGoogle ScholarCrossref
Japanese Research Society for Portal Hypertension, The general rules for recording endoscopic findings on esophageal varices.   Jpn J Surg 1980;10 (1) 84- 87PubMedGoogle ScholarCrossref
Torzilli  GDel Fabbro  DOlivari  NCallida  FMontorsi  MMakuuchi  M Contrast-enhanced ultrasonography during liver surgery.  Br J Surg 2004;91 (9) 1165- 1167PubMedGoogle ScholarCrossref
Torzilli  GMontorsi  MDonadon  M  et al.  “Radical but conservative” is the main goal for ultrasonography-guided liver resection: prospective validation of this approach.  J Am Coll Surg 2005;201 (4) 517- 528PubMedGoogle ScholarCrossref
Torzilli  GMontorsi  MDel Fabbro  DPalmisano  ADonadon  MMakuuchi  M Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence.  Br J Surg 2006;93 (10) 1238- 1246PubMedGoogle ScholarCrossref
Pringle  JH Notes on the arrest of hepatic hemorrhage due to trauma.  Ann Surg 1908;48 (4) 541- 549PubMedGoogle ScholarCrossref
Ijichi  MTakayama  TToyoda  HSano  KKubota  KMakuuchi  M Randomized trial of the usefulness of a bile leakage test during hepatic resection.  Arch Surg 2000;135 (12) 1395- 1400PubMedGoogle ScholarCrossref
Edmondson  HASteiner  PE Primary carcinoma of the liver: a study of 100 cases among 48900 necropsies.  Cancer 1954;7 (3) 462- 503PubMedGoogle ScholarCrossref
Torzilli  GOlivari  NDel Fabbro  D  et al.  Bilirubin level fluctuation in drain discharge after hepatectomies justifies long-term drain maintenance.  Hepatogastroenterology 2005;52 (64) 1206- 1210PubMedGoogle Scholar
Cillo  UVitale  AGrigoletto  F  et al.  Prospective validation of the Barcelona Clinic Liver Cancer staging system.  J Hepatol 2006;44 (4) 723- 731PubMedGoogle ScholarCrossref
Bruix  JSherman  MPractice Guidelines Committee, American Association for the Study of Liver Diseases, Management of hepatocellular carcinoma.  Hepatology 2005;42 (5) 1208- 1236PubMedGoogle ScholarCrossref
Schroeder  RAMarroquin  CEBute  BPKhuri  SHenderson  WGKuo  PC Predictive indices of morbidity and mortality after liver resection.  Ann Surg 2006;243 (3) 373- 379PubMedGoogle ScholarCrossref
Raut  CPIzzo  FMarra  P  et al.  Significant long-term survival after radiofrequency ablation of unresectable hepatocellular carcinoma in patients with cirrhosis.  Ann Surg Oncol 2005;12 (8) 616- 628PubMedGoogle ScholarCrossref
Mazzaferro  VRomito  RSchiavo  M  et al.  Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis.  Hepatology 2006;44 (6) 1543- 1554PubMedGoogle ScholarCrossref
Takayasu  KArii  SIkai  I  et al. Liver Cancer Study Group of Japan, Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.  Gastroenterology 2006;131 (2) 461- 469PubMedGoogle ScholarCrossref
Vetter  DWenger  JJBergier  JMDoffoel  MBockel  R Transcatheter oily chemoembolization in the management of advanced hepatocellular carcinoma in cirrhosis: results of a Western comparative study in 60 patients.  Hepatology 1991;13 (3) 427- 433PubMedGoogle ScholarCrossref
Bronowicki  JPVetter  DDumas  F  et al.  Transcatheter oily chemoembolization for hepatocellular carcinoma: a 4-year study of 127 French patients.  Cancer 1994;74 (1) 16- 24PubMedGoogle ScholarCrossref
Fong  YSun  RLJarnagin  WBlumgart  LH An analysis of 412 cases of hepatocellular carcinoma at a Western center.  Ann Surg 1999;229 (6) 790- 799PubMedGoogle ScholarCrossref
Belghiti  JRegimbeau  JMDurand  F  et al.  Resection of hepatocellular carcinoma: a European experience on 328 cases.  Hepatogastroenterology 2002;49 (43) 41- 46PubMedGoogle Scholar
Teh  SHChristein  JDonohue  J  et al.  Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-stage Liver Disease (MELD) score predicts perioperative mortality.  J Gastrointest Surg 2005;9 (9) 1207- 1215PubMedGoogle ScholarCrossref
Miyagawa  SMakuuchi  MKawasaki  SKakazu  T Criteria for safe hepatic resection.  Am J Surg 1995;169 (6) 589- 594PubMedGoogle ScholarCrossref
Lau  HMan  KFan  STYu  WCLo  CMWong  J Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy.  Br J Surg 1997;84 (9) 1255- 1259PubMedGoogle ScholarCrossref
Redaelli  CADufour  JFWagner  M  et al.  Preoperative galactose elimination capacity predicts complications and survival after hepatic resection.  Ann Surg 2002;235 (1) 77- 85PubMedGoogle ScholarCrossref
Poon  RTFan  ST Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome.  Liver Transpl 2004;10 (2) ((suppl 1)) S39- S45PubMedGoogle ScholarCrossref
Di Stefano  DRde Baere  TDenys  A  et al.  Preoperative percutaneous portal vein embolization: evaluation of adverse events in 188 patients.  Radiology 2005;234 (2) 625- 630PubMedGoogle ScholarCrossref
Azoulay  DCastaing  DSmail  A  et al.  Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization.  Ann Surg 2000;231 (4) 480- 486PubMedGoogle ScholarCrossref
Elias  DOuellet  JFDe Baere  TLasser  PRoche  A Preoperative selective portal vein embolization before hepatectomy for liver metastases: long-term results and impact on survival.  Surgery 2002;131 (3) 294- 299PubMedGoogle ScholarCrossref
Grazi  GLErcolani  GPierangeli  F  et al.  Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value.  Ann Surg 2001;234 (1) 71- 78PubMedGoogle ScholarCrossref
Makuuchi  MTakayama  TGunven  PKosuge  TYamazaki  SHasegawa  H Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients.  World J Surg 1989;13 (5) 644- 648PubMedGoogle ScholarCrossref
Torzilli  GGambetti  ADel Fabbro  D  et al.  Techniques for hepatectomies without blood transfusion focusing on interpretation of postoperative anemia.  Arch Surg 2004;139 (10) 1061- 1065PubMedGoogle ScholarCrossref
Capussotti  LFerrero  AVigano  LMuratore  APolastri  RBouzari  H Portal hypertension: contraindication to liver surgery?  World J Surg 2006;30 (6) 992- 999PubMedGoogle ScholarCrossref
Llovet  JMFuster  JBruix  J Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.  Hepatology 1999;30 (6) 1434- 1440PubMedGoogle ScholarCrossref
Keiding  SVilstrup  H Intrahepatic heterogeneity of hepatic venous pressure gradient in human cirrhosis.  Scand J Gastroenterol 2002;37 (8) 960- 964PubMedGoogle ScholarCrossref
Wadhawan  MDubey  SSharma  BCSarin  SKSarin  SK Hepatic venous pressure gradient in cirrhosis: correlation with the size of varices, bleeding, ascites, and Child's status.  Dig Dis Sci 2006;51 (12) 2264- 2269PubMedGoogle ScholarCrossref
Veltri  AMoretto  PDoriguzzi  APagano  ECarrara  GGandini  G Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC).  Eur Radiol 2006;16 (3) 661- 669PubMedGoogle ScholarCrossref
Molinari  MKachura  JRDixon  E  et al.  Transarterial chemoembolisation for advanced hepatocellular carcinoma: results from a North American cancer centre.  Clin Oncol (R Coll Radiol) 2006;18 (9) 684- 692Google ScholarCrossref
Gollob  JAWilhelm  SCarter  CKelley  SL Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway.  Semin Oncol 2006;33 (4) 392- 406PubMedGoogle ScholarCrossref
Yoon  SSKim  SHGonen  M  et al.  Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases.  Ann Surg Oncol 2006;13 (3) 353- 362PubMedGoogle ScholarCrossref
Torzilli  GPalmisano  ADel Fabbro  D  et al.  Contrast-enhanced intraoperative ultrasonography during surgery for hepatocellular carcinoma in liver cirrhosis: is it useful or useless? a prospective cohort study of our experience.  Ann Surg Oncol 2007;14 (4) 1347- 1355PubMedGoogle ScholarCrossref
Poon  RTFan  STNg  IOWong  J Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal.  Ann Surg 2000;231 (4) 544- 551PubMedGoogle ScholarCrossref
Ochiai  TTakayama  TInoue  K  et al.  Hepatic resection with and without surgical margins for hepatocellular carcinoma in patients with impaired liver function.  Hepatogastroenterology 1999;46 (27) 1885- 1889PubMedGoogle Scholar
Shi  MGuo  RPLin  XJ  et al.  Partial hepatectomy with wide versus narrow resection margin for solitary hepatocellular carcinoma: a prospective randomized trial.  Ann Surg 2007;245 (1) 36- 43PubMedGoogle ScholarCrossref
Matsui  YTerakawa  NSatoi  S  et al.  Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: clinical role of the no-margin resection.  Arch Surg 2007;142 (7) 596- 602PubMedGoogle ScholarCrossref
Veronesi  USaccozzi  RDel Vecchio  M  et al.  Comparing radical mastectomy with quadrantectomy, axillary dissection, and radiotherapy in patients with small cancers of the breast.  N Engl J Med 1981;305 (1) 6- 11PubMedGoogle ScholarCrossref
Original Article
November 17, 2008

Hepatectomy for Stage B and Stage C Hepatocellular Carcinoma in the Barcelona Clinic Liver Cancer Classification: Results of a Prospective Analysis

Author Affiliations

Author Affiliations: Third Department of Surgery, University of Milan School of Medicine, Istituto Clinico Humanitas Istituto Di Ricovero e Cura a Carattere Scientifico, Rozzano, Milan, Italy.

Arch Surg. 2008;143(11):1082-1090. doi:10.1001/archsurg.143.11.1082

Hypothesis  Using an algorithm for selection of patients with hepatocellular carcinoma (HCC) for surgery, Barcelona Clinic Liver Cancer (BCLC) classification stage B and stage C disease is not a contraindication.

Design  Prospective cohort study.

Setting  University tertiary care hospital.

Patients  Among 163 consecutive patients with HCC, 120 (73.6%) underwent surgery; 113 of 120 (94.2%) underwent resection. Of 113 patients, 61 (54.0%) had BCLC stage 0 or A disease, 24 (21.2%) had stage B disease, and 28 (24.8%) had stage C disease.

Interventions  Surgical strategy was based on the relationship of the tumor to the intrahepatic vascular structures on intraoperative ultrasonography.

Main Outcome Measures  Mortality, morbidity, rate of cut edge local recurrences, and long-term outcome were evaluated. P < .05 was considered statistically significant.

Results  Hospital mortality was 0.9%. The overall morbidity was 27.4%, and major morbidity was 3.5%. After a median follow-up of 24 months (range, 1-65 months), there was no cut edge recurrence. For patients with BCLC stages 0 or A, B, and C disease, the 3-year overall survival rates were 81%, 67%, and 74%, respectively (P =.24); the 3-year disease-free survival rates were 30%, 35%, and 15%, respectively (P =.85); and the 3-year hepatic disease-free survival rates were 39%, 44%, and 17%, respectively (P =.79).

Conclusions  Patients with BCLC stage B and stage C HCC can tolerate hepatic resection with low mortality, acceptable morbidity, and survival benefits if resection is performed under strict intraoperative ultrasonographic guidance. These results should prompt revision of the BCLC recommendations.